Advertisement
Journal Home
Search for

Volume 36, Issue 10, Page 31 (October 2008)


View previous. 42 of 61 View next.

Efavirenz May Have Edge for Advanced HIV

SUSAN LONDON (Contributing Writer)

MEXICO CITY — Efavirenz twice daily is at least as effective as once-daily lopinavir/ritonavir, and likely more so, when it used as part of highly active antiretroviral therapy for untreated advanced HIV infection.

PII: S0270-6644(08)70719-7

doi:10.1016/S0270-6644(08)70719-7


View previous. 42 of 61 View next.